XHXin He

Xin He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xin He has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Baojian Xin

    Key Laboratory of Oral Diseases Research of Anhui Province, College & Hospital of Stomatology, Anhui Medical University, Hefei 230032, China

    1 shared publication
  • Dawei Mi

    Key Laboratory of Oral Diseases Research of Anhui Province, College & Hospital of Stomatology, Anhui Medical University, Hefei 230032, China

    1 shared publication
  • Fanglong Wu

    State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Frontier Innovation Center for Dental Medicine Plus, Department of Oral Medicine, West China Hospital of Stomatology Sichuan University Chengdu Sichuan China

    1 shared publication
  • Hengguo Zhang

    College & Hospital of Stomatology, Anhui Medical University, Anhui Provincial Key Laboratory of Oral Diseases Research, China

    1 shared publication
  • Hongdang Xu

    State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu, People’s Republic of China

    1 shared publication
  • Hongmei Zhou

    State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Frontier Innovation Center for Dental Medicine Plus, Department of Oral Medicine, West China Hospital of Stomatology Sichuan University Chengdu Sichuan China

    1 shared publication

Latest Publications

  • Open Access

    Artificial Intelligence Diagnosing of Oral Lichen Planus: A Comparative Study

    by Sensen Yu, Wansu Sun, Dawei Mi, Siyu Jin, Xing Wu, Baojian Xin, Hengguo Zhang, Yuanyin Wang, Xiaoyu Sun, Xin He

    Early diagnosis of oral lichen planus (OLP) is challenging, which traditionally is dependent on clinical experience and subjective interpretation. Artificial intelligence (AI) technology has been widely applied in objective and rapid diagnoses. In this study, we aim to investigate the potential of AI diagnosis in OLP and evaluate its effectiveness in improving diagnostic accuracy and accelerating clinical decision making. A total of 128 confirmed OLP patients were included, and lesion images from various anatomical sites were collected. The diagnosis was performed using AI platforms, including ChatGPT-4O, ChatGPT (Diagram-Date extension), and Claude Opus, for AI directly identification and AI pre-training identification. After OLP feature training, the diagnostic accuracy of the AI platforms significantly improved, with the overall recognition rates of ChatGPT-4O, ChatGPT (Diagram-Date extension), and Claude Opus increasing from 59%, 68%, and 15% to 77%, 80%, and 50%, respectively. Additionally, the pre-training recognition rates for buccal mucosa reached 94%, 93%, and 56%, respectively. However, the AI platforms performed less effectively when recognizing lesions in less common sites and complex cases; for instance, the pre-training recognition rates for the gums were only 60%, 60%, and 20%, demonstrating significant limitations. The study highlights the strengths and limitations of different AI technologies and provides a reference for future AI applications in oral medicine.


  • PRDX6 alleviates lipopolysaccharide-induced inflammation and ferroptosis in periodontitis

    by Wen-Ying Yang, Xiang Meng, Yue-Rong Wang, Qing-Qing Wang, Xin He, Xiao-Yu Sun, Nan Cheng, Lei Zhang

    Periodontitis is a progressive and inflammatory oral disease and results in the damage of the supporting tissues of teeth. Peroxiredoxin 6 (PRDX6) is an antioxidant enzyme identified as a regulator...


  • Open Access

    TGF-βRII regulates glucose metabolism in oral cancer-associated fibroblasts via promoting PKM2 nuclear translocation

    by Fanglong Wu, Shimeng Wang, Qingxiang Zeng, Junjiang Liu, Jin Yang, Jingtian Mu, Hongdang Xu, Lanyan Wu, Qinghong Gao, Xin He, et al.

    Cancer-associated fibroblasts (CAFs) are highly heterogeneous and differentiated stromal cells that promote tumor progression via remodeling of extracellular matrix, maintenance of stemness, angiogenesis, and modulation of tumor metabolism. Aerobic glycolysis is characterized by an increased uptake of glucose for conversion into lactate under sufficient oxygen conditions, and this metabolic process occurs at the site of energy exchange between CAFs and cancer cells. As a hallmark of cancer, metabolic reprogramming of CAFs is defined as reverse Warburg effect (RWE), characterized by increased lactate, glutamine, and pyruvate, etc. derived from aerobic glycolysis. Given that the TGF-β signal cascade plays a critical role in RWE mainly through metabolic reprogramming related proteins including pyruvate kinase muscle isozyme 2 (PKM2), however, the role of nuclear PKM2 in modifying glycolysis remains largely unknown. In this study, using a series of in vitro and in vivo experiments, we provide evidence that TGF-βRII overexpression suppresses glucose metabolism in CAFs by attenuating PKM2 nuclear translocation, thereby inhibiting oral cancer tumor growth. This study highlights a novel pathway that explains the role of TGF-βRII in CAFs glucose metabolism and suggests that targeting TGF-βRII in CAFs might represent a therapeutic approach for oral cancer.